Products Categories
  • Ms.jocelyn
    Tel: +86-21-64057580

  • Mobile:15924322184
  • Tel:+86-21-64057580
  • Fax:021-64057886
  • URL:http://www.jindunchemical.cn
  • Province/state:SHANGHAI
  • City:SHANGHAI
  • Street:No.9, Lane 3599, Qixin road, Minhang district, Shanghai, China
  • MaxCard:
Home > Products >  Enzalutamide

Enzalutamide CAS NO.915087-33-1

  • Min.Order: 100 Gram
  • Payment Terms: L/C,D/A,D/P,T/T
  • Product Details

Keywords

  • Enzalutamide
  • 915087-33-1
  • pharmaceutical intermediates

Quick Details

  • ProName: Enzalutamide
  • CasNo: 915087-33-1
  • Molecular Formula: C21H16F4N4O2S
  • Appearance: Clear light yellow Liquid
  • Application: pharmaceutical intermediates
  • DeliveryTime: Within ten working day
  • PackAge: 1KG;10KG;100KG
  • Port: Shang hai
  • ProductionCapacity: 100 Kilogram/Month
  • Purity: 99%
  • Storage: Keep container closed and store in coo...
  • Transportation: by sea or by air
  • LimitNum: 100 Gram

Superiority

Xtandi and enzalutamide are oral androgen like receptor antagonists. Currently, they have been approved by clinical research and FDA (food and Drug Administration) for the treatment of metastatic castration tolerant prostate cancer after chemotherapy (i.e. patients with prostate cancer whose tumor or cancer cells are still growing after chemotherapy), which can prolong the survival of patients. The incidence rate of incidence of prostate cancer in the United States is very high. Nearly 240 thousand patients (the highest in all cancers) are newly added each year, and nearly 30 thousand deaths occur each year (second only to lung, breast and colorectal cancer). China has a low incidence rate. Enzalutamide is an androgen receptor inhibitor. Its target is different from cabataxel approved in 2010 and abiraterone approved in 2011. It can competitively inhibit the binding of androgen and receptor, and inhibit the nuclear transport of androgen chemobook receptor and the interaction between androgen receptor and DNA. In vitro experiments show that enzalutamide can inhibit prostate cancer cells The main metabolite of enzalutamide is n-demethylenzalutamide, which has similar inhibitory activity in vitro as enzalutamide. The recommended adult dose of enzalutamide is 160 mg per day, which can be absorbed rapidly after administration, and the plasma concentration reaches the highest level within 0.5-3 H, The average terminal half-life was 5.8 days, and the main metabolic enzymes were cyp2c8 and CYP3A4. The drug should not be used in combination with strong cyp2c8 inhibitors (such as gemfibrozil, gemfibrozil). If co administration is needed, the dose of enzalutamide should be reduced to 80 mg, once a day.

Details

COMPANY INTRODUCTION

JIN DUN CHEMICAL belongs to JIN DUN GROUP. It is a professional enterprise dedicated to the development and production of special (meth)acrylate monomers. The head office is located in Shanghai city, near Hongqiao airport.The R&D center of JIN DUN is located in Ningbo city, Zhejiang province.  

JIN DUN CHEMICAL focus on the coating, automobile, electricity and pharmaceutical area, always try best to be the professional supplier of new raw material for the advanced material in coating, automobile chemicals, electricity chemicals and pharmaceutical intermediate.

The EU company of JIN DUN CHEMICAL located at Frankfurt in Germany. It makes us service our customer better in EU, but also takes more valued information for our creation and future developing.

Welcome our customers and friends to visit our company.

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog